About GPhA

America's Generic Pharmaceutical Industry Provides Timely Access to Affordable Medicines

The generic drug approval process is complicated. And that's okay. But what's NOT okay is when brand companies try to use this process to extend product monopolies by submitting numerous questionable or frivolous patents on the same drug to the FDA. Instead of focusing on innovating novel drugs for other medical conditions, brand companies can focus on "innovating" new patents for the same drug and conditions. And that's not good for consumers.

To spark competition in the market and ensure there are checks and balances, Congress provided an incentive for generic companies to challenge questionable or frivolous brand patents -- patents that typically add little in the way of innovation.

America's generic drug industry has stepped up to the challenge and the result has been more timely access to generic drugs -- and tens of billions of dollars in savings for consumers.

Removing needless market barriers leads to more timely access to affordable drugs and produces greater competition.

• Learn more about some of the issues affecting the industry.